INTRODUCTION
Despite profound improvement in prognosis for ST-elevation myocardial infarction (STEMI) patients without cardiogenic shock (CS), mortality rates remain high in STEMI complicated by CS. Historically, mortality rates for STEMI complicated by CS were as high as 70-80% 1 . Since prompt reperfusion has been shown to reduce short-and long term mortality by Hochman et al 2, 3 , it has become standard of treatment for STEMI patients presenting in CS. However, in-hospital mortality rates are still around 40% 4 , despite prompt reperfusion therapy. The identification of new predictors of mortality may help guide the exploration of new therapeutic pathways and the development of additional treatment strategies besides primary PCI, in order to improve outcome in these patients. Right ventricular dysfunction has been shown to be a predictor of mortality in STEMI patients without cardiogenic shock 5 . Moreover, it has been shown to be a marker for adverse prognosis in patients with heart failure 6 . However, as echocardiographic evaluation in STEMI complicated by cardiogenic shock is predominantly directed at evaluating left ventricular function and the presence of mechanical complications, limited data are available on the prognostic value of right ventricular dysfunction in these patients. In the current study, we investigate the prognostic value of right ventricular dysfunction on admission in STEMI patients presenting in CS and treated with primary percutaneous coronary intervention (PCI).
METHODS

Study population
From January 1997 through March 2005, all consecutive STEMI patients treated with primary PCI in our hospital were entered into a dedicated database (n=3038). All patients prospectively registered by the attending cardiologist as being in CS on admission were selected (n=292; 9.6% of total population) This cohort has been described previously 7, 8 . Standard 2-dimensional transthoracic echocardiograms were performed in 206 patients. All echocardiograms were performed after PCI within the first 24 hours after admission. Right ventricular (RV) function could be assessed in 184 patients, who constituted the final study cohort for the current analysis. RV function was assessed by measuring tricuspid annular plane systolic excursion (TAPSE), which has been described as an accurate and easily applicable method for the quick evaluation of RV function 9 .
Definitions
Acute STEMI was defined as acute myocardial infarction with ST-segment elevation of >0.1 mV in two or more contiguous leads. RV dysfunction was defined as TAPSE of ≤14 mm. CS was defined according to the SHOCK trial 2 as a systolic blood pressure equal to or below 90 mmHg for at least 30 minutes or vasopressors required to maintain blood pressure >90 mmHg, evidence of end-organ hypoperfusion (e.g.: urine output <30 mL or cold, diaphoretic extremities or altered mental status) and evidence of elevated filling pressures (e.g. pulmonary congestion on examination or chest radiograph). Treatment of CS was at the discretion of the operator and included, besides primary PCI, fluid resuscitation, endotracheal intubation, placement of an intra-aortic balloon pump (IABP) and catecholamine administration. Coronary flow was graded angiographically by the operator according to the Thrombolysis in Myocardial Infarction (TIMI) criteria (TIMI 0-3).
Endpoints
The primary endpoint was all-cause mortality at 4 years.
Statistical analysis
Data were analyzed using the statistical Package for the Social Sciences (SPSS inc., Chicago, IL, USA; version 14.0.1). Continuous data are presented as mean +/-standard deviation (SD) (median and quartiles for skewed variables). Categorical data are presented as percentages. TAPSE was dichotomized to TAPSE ≤14 mm and TAPSE >14, as has been established previously 9, 10 . Left ventricular function was dichotomized to left ventricular ejection fraction (LVEF) <40% and LVEF >40%. Age was analyzed as a continuous variable. All p values <0.05 were considered statistically significant. Differences between groups were tested using the χ 2 test for categorical variables and the student's t-test for normally distributed continuous variables. Kaplan-Meier curves for both groups were constructed and survival differences were tested using the log-rank statistic. Backward stepwise selection Cox-regression analysis was performed to identify independent predictors of 4-year survival. In the initial model, RV function was included, together with previously established predictors of survival (age, gender, the presence of previous myocardial infarctions, glucose level on admission, diabetes on admission, haemoglobin level on admission, creatinin level on admission, LVEF <40%, TIMI flow<3 after PCI and the presence of multivessel disease). After stepwise backward selection, only RV function, age, LVEF <40% and glucose on admission remained in the model as independent predictors for survival.
RESULTS
Patient characteristics
The overall study cohort consisted of 184 patients who underwent echocardiographic evaluation of RV function. The cohort consisted of 120 men (65%), with a mean age of 64 years. Forty-four patients (24%) had a previous myocardial infarction; multivessel disease was present in 103 patients (56%). The culprit lesion was located in the left anterior descending (LAD) artery in 95 patients (52%), in the left circumflex artery Baseline characteristics of the study cohort according to the presence or absence of RV dysfunction are displayed in Table 2 .
Survival
Overall 1-year survival in the cohort of 292 patients was 58%, as described in previous reports 7, 8 . One-year survival in the overall study cohort was 63%. In patients with RV dysfunction, 1-year survival was 39%, whereas in patients without RV dysfunction, 1-year survival was 78% (P <0.001). The Kaplan-Meier estimate of 4-year survival in Table 4 remained in the model patients with and without RV dysfunction was 33% and 73%, respectively (p<0.001).
The Kaplan-Meier estimate of 4-year survival in patients with an LVEF >40% and TAPSE >14 was 95%. In patients with an LVEF >40% and TAPSE ≤14, however, the KaplanMeier estimate of 4-year survival was 73%. In patients with an LVEF <40% and normal RV function, the Kaplan-Meier estimate of 4-year survival was 60%, whereas in patients with an LVEF <40% and RV dysfunction, estimated 4-year survival was 27%. Survival data are displayed in Table 3 ; survival curves including numbers of patients at risk are displayed in Figures 1 and 2 . On Cox-regression analysis, RV dysfunction was shown to be an independent predictor of mortality, with a cumulative hazard ratio (HR) for mortality of 2.1 (95% CI 1.3 -3.5; p=0.002) when adjusted for age, LVEF <40%, and glucose on admission. Table 4 depicts the results of Cox-regression analysis.
DISCUSSION
Our data suggest that the presence of RV dysfunction on admission, defined as TAPSE ≤14 mm on early echocardiography (within 24 hours after PCI), is an independent predictor of short-and long-term mortality in STEMI patients presenting with CS. Recently, Hamon et al 5 demonstrated RV dysfunction to be a predictor of an adverse prognosis in STEMI without CS, in a meta-analysis of data from 22 studies. However, in STEMI complicated by CS, limited and conflicting data are available. Mendes et al 11 have evaluated the prognostic value of RV function in a sub-study from the SHOCK trial. In this study, no difference was demonstrated between groups of LV shock patients with and without RV dysfunction. However, in patients with RV dysfunction, the presence of RV dilatation predicted an improved prognosis, with significantly greater 12-month survival. In another report, derived from the SHOCK registry 12 , the outcomes of 'isolated RV shock' were shown to be similar to the outcomes in patients with LV shock, despite a more favorable risk profile in the RV shock patients. Importantly, the definitions of RV dysfunction, RV infarction and RV involvement vary among these studies. In the study by Mendes et al, RV dysfunction was qualitatively assessed on echocardiography, based on visual appreciation of both longitudinal function and free wall motion. In the report from the SHOCK registry, the diagnosis of isolated RV shock was based on a combination of clinical, electrocardiographic, hemodynamic and echocardiographic findings. In our study, no significant differences in infarct-related artery (IRA) and subsequently, infarct location could be demonstrated between patients with and without RV dysfunction. However, although not statistically significant, more RCA-related infarctions were present in patients with RV dysfunction. Notwithstanding these findings however, our data suggest that RV dysfunction does not occur exclusively in association with RCA-related infarctions. In many previously conducted studies in STEMI, RV dysfunction, RV involvement or RV infarction have been predominantly related to inferior myocardial infarctions 13, 14 . However, some previous reports have described right ventricular involvement in anteroseptal myocardial infarctions [15] [16] [17] . The mechanism is unclear, but it has been suggested to occur in the case of LAD collaterals, supplying blood to the right ventricle 18 . In fact, observations during myocardial septal alcohol ablations have shown that the first septal branch splits into 2 vessels: 1 that typically extends to the right side of the septum (and the moderator band) and another that supplies the left side of the upper septum 19 . This finding may at least provide a partial explanation for the development of RV dysfunction in LAD related STEMI. Furthermore, our data suggest that especially in patients with LV dysfunction, RV dysfunction is associated with an increasingly worse prognosis. The relationship between LV and RV function can be viewed from several perspectives. The right ventricle is responsible for generating LV preload; which plays a crucial role in total cardiac output and the subsequent venous return, responsible for RV preload itself. Moreover, in systole, LV contraction contributes significantly to RV pressure and output 20 . Thus, in patients with large anterior myocardial infarctions, decreased LV output decreases the return of blood to the right ventricle, thereby compromising RV preload. Moreover, the contribution of LV contraction to RV systole is diminished. Thus, a detrimental vicious cycle develops of LV dysfunction leading to RV dysfunction. On the other hand, RV dysfunction itself diminishes preload to the left ventricle, thereby further compromising LV output.
Clinical implications
As suggested by our data, the presence of RV dysfunction on early echocardiography is an important predictor of an adverse prognosis, both short-and long-term, in STEMI patients presenting with CS on admission. Especially in the case of combined LV and RV dysfunction, prognosis is very poor. The majority of diagnostic and therapeutic approaches for cardiogenic shock are predominantly directed at the left ventricle; percutaneous left ventricular support devices, such as the Intra-aortic balloon pump and the Impella LP2.5 device, are often implanted in the setting of STEMI complicated by CS. Much less attention has been paid to the right ventricle, however, as a possible diagnostic and therapeutic target in these patients. Since our data suggest that RV dysfunction does play an important role, both diagnosis and management should perhaps more often be directed at the right ventricle as well. An important finding is also the fact that RV dysfunction is not only related to right coronary artery involvement. Although this phenomenon has been described and partially understood, it emphasizes the importance of RV analysis even when the left coronary artery is the culprit artery.
With the upcoming availability of a newly developed percutaneous right ventricular assist device, in the near future, percutaneous RV support in the acute setting may become a feasible therapeutic strategy.
Study limitations
First of all, the retrospective nature of our study is an important limitation. Although patients have been prospectively entered into a dedicated database, limited electrocardiographic data are available. Although RV function was assessed by measuring TAPSE, no detailed echocardiographic data, such as data on ventricular dimensions or the severity of tricuspid regurgitation, are available from our database. Echocardiograms have been performed in 206 of 292 patients. RV function could be measured in 184 of 206 patients, which may have induced some selection bias. However, the 1-year survival of 63% in the study cohort was almost similar to the 1-year survival of 58% in the overall cohort. Our study is a single center study with a relatively small sample size. However, patients have been exclusively treated with primary PCI. In addition, TAPSE ≤14 mm remained an independent predictor for survival, when adjusted for several established predictors of survival, such as glucose on admission, LVEF <40% and age.
CONCLUSION
RV dysfunction is an independent predictor for short-and long-term mortality in STEMI patients presenting in CS and treated with primary PCI. Moreover, RV dysfunction does not occur exclusively during RCA involvement. Therefore, although diagnostic evaluation and treatment of STEMI complicated by CS has been directed predominantly at the left ventricle, our data suggest that the right ventricle may be an important new diagnostic as well as a therapeutic target.
